These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32099966)

  • 1. Histone deacetylases in vascular permeability and remodeling associated with acute lung injury.
    Kovacs L; Kovacs-Kasa A; Verin AD; Fulton D; Lucas R; Su Y
    Vessel Plus; 2018; 2():. PubMed ID: 32099966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology.
    Patil RS; Maloney ME; Lucas R; Fulton DJR; Patel V; Bagi Z; Kovacs-Kasa A; Kovacs L; Su Y; Verin AD
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6.
    Borgas D; Chambers E; Newton J; Ko J; Rivera S; Rounds S; Lu Q
    Am J Respir Cell Mol Biol; 2016 May; 54(5):683-96. PubMed ID: 26452072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate stiffness-dependent exacerbation of endothelial permeability and inflammation: mechanisms and potential implications in ALI and PH (2017 Grover Conference Series).
    Karki P; Birukova AA
    Pulm Circ; 2018; 8(2):2045894018773044. PubMed ID: 29714090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule destabilization caused by particulate matter contributes to lung endothelial barrier dysfunction and inflammation.
    Karki P; Meliton A; Sitikov A; Tian Y; Ohmura T; Birukova AA
    Cell Signal; 2019 Jan; 53():246-255. PubMed ID: 30339829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylases in the Inflamed Intestinal Epithelium-Promises of New Therapeutic Strategies.
    Gerbeth L; Glauben R
    Front Med (Lausanne); 2021; 8():655956. PubMed ID: 33842512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
    Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
    Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients.
    Wawrzyniak P; Wawrzyniak M; Wanke K; Sokolowska M; Bendelja K; Rückert B; Globinska A; Jakiela B; Kast JI; Idzko M; Akdis M; Sanak M; Akdis CA
    J Allergy Clin Immunol; 2017 Jan; 139(1):93-103. PubMed ID: 27312821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway.
    Li LF; Lee CS; Lin CW; Chen NH; Chuang LP; Hung CY; Liu YY
    PLoS One; 2017; 12(2):e0172571. PubMed ID: 28234968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylases 3 deletion restrains PM2.5-induced mice lung injury by regulating NF-κB and TGF-β/Smad2/3 signaling pathways.
    Gu LZ; Sun H; Chen JH
    Biomed Pharmacother; 2017 Jan; 85():756-762. PubMed ID: 27919737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury.
    Kása A; Csortos C; Verin AD
    Tissue Barriers; 2015; 3(1-2):e974448. PubMed ID: 25838980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
    Eom GH; Kook H
    Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases and cardiovascular cell lineage commitment.
    Yang JY; Wang Q; Wang W; Zeng LF
    World J Stem Cells; 2015 Jun; 7(5):852-8. PubMed ID: 26131315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease.
    Wang ZY; Qin W; Yi F
    J Geriatr Cardiol; 2015 Mar; 12(2):153-64. PubMed ID: 25870619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation.
    Lkhagva B; Kao YH; Chen YC; Chao TF; Chen SA; Chen YJ
    Eur J Pharmacol; 2016 Jun; 781():250-7. PubMed ID: 27089819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylases function as novel potential therapeutic targets for cancer.
    Zhang H; Shang YP; Chen HY; Li J
    Hepatol Res; 2017 Feb; 47(2):149-159. PubMed ID: 27457249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of HDACs in the Responses of Innate Immune Cells and as Targets in Inflammatory Diseases.
    Hu Y; Suliman BA
    Adv Exp Med Biol; 2017; 1024():91-110. PubMed ID: 28921466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury.
    Yi L; Huang X; Guo F; Zhou Z; Chang M; Huan J
    Front Cell Infect Microbiol; 2017; 7():357. PubMed ID: 28824887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium.
    Lee DY; Chiu JJ
    J Biomed Sci; 2019 Aug; 26(1):56. PubMed ID: 31387590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.